These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9443681)

  • 21. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
    Tsai CP; Chiu MC; Yen DJ; Guo YC; Yuan CL; Lee TC
    Acta Neurol Taiwan; 2005 Jun; 14(2):61-8. PubMed ID: 16008164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemifacial spasm complicating diabetic ketoacidosis.
    Bandyopadhyay SK; Dutta A
    J Assoc Physicians India; 2005 Jul; 53():649-50. PubMed ID: 16190139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
    Yin S; Stucker FJ; Nathan CO
    J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin A in clinical medicine.
    Elston JS
    J Physiol (Paris); 1990; 84(4):285-9. PubMed ID: 2079665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Headache in hemifacial spasm patients.
    Peeraully T; Tan SF; Fook-Chong SM; Prakash KM; Tan EK
    Acta Neurol Scand; 2013 May; 127(5):e24-7. PubMed ID: 23311349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.
    Kalra HK; Magoon EH
    Ophthalmic Surg; 1990 May; 21(5):335-8. PubMed ID: 2381655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemifacial spasms caused by neurovascular compression].
    Mustafa MK; van Weerden TW; Mooij JJ
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):273-7. PubMed ID: 12622002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of blepharospasm, hemifacial spasm and strabismus with botulinum a toxin.
    Dai Z; Wang YC
    Chin Med J (Engl); 1992 Jun; 105(6):476-80. PubMed ID: 1451548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of idiopathic hemifacial spasm with radiosurgery or hypofractionated stereotactic radiotherapy: preliminary results.
    Fraioli MF; Moschettoni L; Fraioli C; Strigari L
    Minim Invasive Neurosurg; 2010 Feb; 53(1):34-6. PubMed ID: 20376743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment.
    Tunç T; Cavdar L; Karadağ YS; Okuyucu E; Coşkun O; Inan LE
    J Clin Neurosci; 2008 Mar; 15(3):253-6. PubMed ID: 18191574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated hemifacial spasm presenting as unilateral, involuntary ear movements.
    Klimkowicz-Mrowiec A; Kasprzyk-Galon K; Barbano R
    Parkinsonism Relat Disord; 2018 Apr; 49():106-107. PubMed ID: 29329937
    [No Abstract]   [Full Text] [Related]  

  • 40. Movement Disorders in Multiple Sclerosis: An Update.
    Ghosh R; Roy D; Dubey S; Das S; Benito-León J
    Tremor Other Hyperkinet Mov (N Y); 2022; 12():14. PubMed ID: 35601204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.